Global Information Lookup Global Information

Losmapimod information


Losmapimod
Legal status
Legal status
  • US: Investigational New Drug
Identifiers
IUPAC name
  • 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
CAS Number
  • 585543-15-3 ☒N
PubChem CID
  • 11552706
IUPHAR/BPS
  • 7835
ChemSpider
  • 9727484 ☒N
UNII
  • F2DQF16BXE
KEGG
  • D09639 ☒N
ChEMBL
  • ChEMBL1088752 ☒N
CompTox Dashboard (EPA)
  • DTXSID30974109 Edit this at Wikidata
ECHA InfoCard100.158.124 Edit this at Wikidata
Chemical and physical data
FormulaC22H26FN3O2
Molar mass383.467 g·mol−1
3D model (JSmol)
  • Interactive image
SMILES
  • C3CC3NC(=O)c(cc(F)c1C)cc1-c(cc2)ncc2C(=O)NCC(C)(C)C
InChI
  • InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28) ☒N
  • Key:KKYABQBFGDZVNQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Losmapimod (GW856553X) is an investigational drug being developed by Fulcrum Therapeutics for the treatment of facioscapulohumeral muscular dystrophy (FSHD); a phase III clinical trial is pending approval. Losmapimod selectively inhibits enzymes p38α/β mitogen-activated protein kinases (MAPKs), which are modulators of DUX4 expression and mediators of inflammation.[1]

  1. ^ Aston NM, Bamborough P, Buckton JB, Edwards CD, Holmes DS, Jones KL, et al. (October 2009). "p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression". Journal of Medicinal Chemistry. 52 (20): 6257–69. doi:10.1021/jm9004779. PMID 19772287.

and 2 Related for: Losmapimod information

Request time (Page generated in 0.5162 seconds.)

Losmapimod

Last Update:

Losmapimod (GW856553X) is an investigational drug being developed by Fulcrum Therapeutics for the treatment of facioscapulohumeral muscular dystrophy (FSHD);...

Word Count : 1842

Facioscapulohumeral muscular dystrophy

Last Update:

molecule drugs can typically be taken by ingestion, rather than injection. Losmapimod, a selective inhibitor of p38α/β mitogen-activated protein kinases, was...

Word Count : 16337

PDF Search Engine © AllGlobal.net